Status:
COMPLETED
Outcomes of Intrathecal Analgesia in Colorectal Surgery
Lead Sponsor:
Mayo Clinic
Conditions:
Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Multimodal analgesia, sometimes including intrathecal analgesia (IA), is essential in any enhanced recovery pathway (ERP). This study aimed to evaluate the safety, feasibility, and optimal IA regimen ...
Eligibility Criteria
Inclusion
- All adult colorectal patients from October 2012 through December 2013 in which patients received single-injection IA as part of a multimodal analgesic strategy for ERP.
- Undergoing an elective colorectal operation (minimally invasive or open)
Exclusion
- Patients aged \< 18 years
- American Society of Anesthesiologists (ASA) 5 and 6 classification
- pregnancy
- failure to provide research authorization.
- emergent operations
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2013
Estimated Enrollment :
601 Patients enrolled
Trial Details
Trial ID
NCT03411109
Start Date
October 1 2012
End Date
December 31 2013
Last Update
January 25 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Jacksonville, Florida, United States, 32224
2
Mayo Clinic
Rochester, Minnesota, United States, 55905